Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001873394-26-000003

President, Research & Develop. sold 25,907 shares at $15.39 ($398,810)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Sethuraman Natarajan President, Research & Develop. 2026-05-04 Sale 10b5-1 −25,907 $15.39 $398,810 216,317 D
Open-market sales · 25,907 sh · avg $15.39 · $398,810
Loading xslF345X06/wk-form4_1777937098.xml…